Richard is a results-driven pharmaceutical operations leader dedicated to transforming client manufacturing capabilities and accelerating their path to success. With deep expertise in GMP operations, process technology transfer, and site readiness, he helps life sciences organizations optimize their facilities, reduce risk, and achieve operational excellence—whether transitioning facilities from startup to full production or implementing complex process improvements.

Holding prior technical operations leadership positions at ReciBioPharm, Thermo Fisher Scientific, Biogen, Sanofi, and Genzyme, he brings a wealth of industry experience and a strong understanding of both strategic and operational challenges faced by top-tier organizations. His proven ability to lead large-scale projects—such as establishing state-of-the-art cGMP ATMP facilities, transitioning viral vector manufacturing into GMP compliance, and streamlining downstream operations—delivers measurable value by minimizing time to market, reducing operational costs, and enhancing product quality.

Richard partners closely with clients to develop tailored strategies, improve supply chain agility, and ensure regulatory compliance, ultimately strengthening their competitive edge. His expertise in risk management, project execution, and organizational leadership ensures clients achieve scalable, compliant, and high-performance manufacturing environments—supporting their long-term growth and innovation goals.